Literature DB >> 23199518

Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients.

Jürgen Vogt1, Johannes Heintze, Klaus J Gutleben, Bogdan Muntean, Dieter Horstkotte, Georg Nölker.   

Abstract

OBJECTIVES: The purpose of this study was to investigate long-term outcomes of freedom from atrial fibrillation (AF) after pulmonary vein (PV) isolation using cryoballoon ablation with balloon-size selection based on individual PV diameters.
BACKGROUND: Data are lacking on long-term outcomes from cryoablation and on the most effective balloon size.
METHODS: This was a prospective observational study involving 605 consecutively enrolled patients with symptomatic paroxysmal AF (n = 579) or persistent AF. Cryoballoon size was based on magnetic resonance imaging and/or conventional angiograms. Patients were followed up every 3 months during the first year after discharge and every 6 months in the second year. After 24 months, follow-up was on an outpatient basis with documented AF episodes recorded.
RESULTS: The PV isolation was achieved without touch-up in 91.1% of patients, using the smaller balloon in 26.7%, the larger balloon in 25.6%, and both balloons in 47.7% of patients. Follow-up data for >12 months (median 30 months; interquartile range 18 to 48 months) were available for 451 patients, 278 (61.6%) of whom were free of AF recurrence with no need for repeat procedures after the 3-month blanking period. Rates of freedom from AF after 1, 2, and 3 repeat procedures (using cryoballoon or radiofrequency ablation with similar success rates) were 74.9%, 76.2%, and 76.9%, respectively. Use of the smaller balloons or both balloons produced the highest rates of long-term freedom from AF. Phrenic nerve palsy occurred in 12 patients (2%), resolving within 3 to 9 months.
CONCLUSIONS: Rates of long-term freedom from AF after cryoballoon ablation are similar to those reported for radiofrequency ablation. A choice between balloons may improve outcomes.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23199518     DOI: 10.1016/j.jacc.2012.09.033

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  47 in total

1.  The novel human gene aprataxin is directly involved in DNA single-strand-break repair.

Authors:  P Mosesso; M Piane; F Palitti; G Pepe; S Penna; L Chessa
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

2.  Immediate and medium-term outcomes of cryoballoon-based pulmonary vein isolation in patients with paroxysmal and persistent atrial fibrillation: single-centre experience.

Authors:  Kudret Aytemir; Ali Oto; Uğur Canpolat; Hamza Sunman; Hikmet Yorgun; Levent Şahiner; Ergün Barış Kaya
Journal:  J Interv Card Electrophysiol       Date:  2013-10-11       Impact factor: 1.900

3.  [Innovative techniques in atrial fibrillation therapy].

Authors:  A Metzner; E Wissner; T Fink; F Ouyang; K-H Kuck
Journal:  Herz       Date:  2015-02       Impact factor: 1.443

4.  Single 3-min freeze per vein ablation strategy with the second-generation cryoballoon for atrial fibrillation in a large cohort of patients: long term outcome after a single procedure.

Authors:  Hugo-Enrique Coutiño; Juan-Pablo Abugattas; Juan Sieira; Francesca Salghetti; Erwin Ströker; Gaetano Paparella; Emmanuel Haine; Varnavas Varnavas; Vincent Umbrain; Muryo Terasawa; Yves De Greef; Pedro Brugada; Saverio Iacopino; Carlo de Asmundis; Gian-Battista Chierchia
Journal:  J Interv Card Electrophysiol       Date:  2018-06-13       Impact factor: 1.900

Review 5.  Recent Advances in Lesion Formation for Catheter Ablation of Atrial Fibrillation.

Authors:  Adam S Barnett; Tristram D Bahnson; Jonathan P Piccini
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-05

6.  Conjoined Inferior Pulmonary Veins during Pulmonary Vein Isolation: Prevalence and Novel Approach for Pulmonary Vein Isolation with Cryoballoon.

Authors:  Jonathan Spagnola; Estelle Torbey; Rob Sangrigoli; John Harding; Marcin Kowalski
Journal:  J Atr Fibrillation       Date:  2015-04-30

Review 7.  The Impact of Advances in Atrial Fibrillation Ablation Devices on the Incidence and Prevention of Complications.

Authors:  Fehmi Keçe; Katja Zeppenfeld; Serge A Trines
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

8.  A long-term evaluation of cryoballoon ablation in 205 atrial fibrillation patients: a single center experience.

Authors:  Alexander Bohó; Silvia Mišíková; Peter Spurný; Erika Komanová; Michal Kerekanič; Marek Hudák; Branislav Stančák
Journal:  Wien Klin Wochenschr       Date:  2015-07-04       Impact factor: 1.704

9.  [Catheter ablation of paroxysmal atrial fibrillation. Optimal approach and result].

Authors:  Shibu Mathew; Andreas Metzner; Feifan Ouyang; Karl-Heinz Kuck; Roland Richard Tilz
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-04-16

10.  Repeat procedures after second-generation cryoballoon ablation as an index procedure for persistent atrial fibrillation: one-year follow-up.

Authors:  Hugo Enrique Coutiño; Carlo de Asmundis; Giacomo Mugnai; Darragh Moran; Valentina De Regibus; Erwin Ströker; Ken Takarada; Diego Ruggiero; Rajin Choudhury; Stefan Beckers; Carla Van Gompel; Jan Poelaert; Saverio Iacopino; Pasquale Filannino; Pedro Brugada; Gian-Battista Chierchia
Journal:  J Interv Card Electrophysiol       Date:  2016-08-25       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.